Erlotinib + sirolimus

DRUG2 trials

Sponsors

Jonsson Comprehensive Cancer Center, Duke University

Conditions

Brain and Central Nervous System TumorsGlioblastomaGliosarcoma

Phase 1

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

CompletedNCT00509431

Jonsson Comprehensive Cancer CenterBrain and Central Nervous System Tumors

Start: 2006-08-31End: 2012-09-30Updated: 2020-07-31

Phase 2

Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

CompletedNCT00672243

Duke UniversityGlioblastoma, Gliosarcoma

Start: 2007-04-30End: 2009-12-31Updated: 2013-08-07